Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults
Status:
Recruiting
Trial end date:
2024-04-29
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to evaluate the antiviral activity of orally administered
VH4004280 and VH4011499 monotherapy over 10 days in human immunodeficiency virus (HIV-1)
infected Treatment-Naïve (TN) participants.